8 insiders reported 8 Form 4 transactions for First Tracks Biotherapeutics, Inc. (TRAX) over the past 18 months (most recent 2026-06-17). Recent activity: FENTON DENNIS M (Director) Buy 6,030 shares, Orwin John A (Director) Buy 6,030 shares, Schmid John P. (Director) Buy 6,030 shares, Marquet Magda (Director) Buy 6,030 shares, Jain Rita (Director) Buy 7,330 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | FENTON DENNIS M | Director | Buy | 6,030 | $0 |
| 2026-06-17 | Orwin John A | Director | Buy | 6,030 | $0 |
| 2026-06-17 | Schmid John P. | Director | Buy | 6,030 | $0 |
| 2026-06-17 | Marquet Magda | Director | Buy | 6,030 | $0 |
| 2026-06-17 | Jain Rita | Director | Buy | 7,330 | $0 |
| 2026-06-17 | Ware J. Anthony | Director | Buy | 6,030 | $0 |
| 2026-04-22 | ANAPTYSBIO, INC | 10% Owner | Sell | 100 | $0 |
| 2026-04-22 | EcoR1 Capital, LLC | 10% Owner | Buy | 4.7M | $65.0M |
Source: SEC Form 4 filings · as of 2026-06-17